Bio-Rad Laboratories (BIO-B) Goodwill (2009 - 2026)

Bio-Rad Laboratories (BIO-B) has 18 years of Goodwill data on file, last reported at $577.1 million in Q1 2026.

• Goodwill for Q1 2026 came in at $577.1 million, up 39.19% year-over-year; the trailing twelve-month figure through Mar 2026 was $577.1 million (up 39.19% YoY), and the FY2025 annual result was $579.8 million, up 41.24% from the prior year.
• Goodwill held at $577.1 million in Q1 2026 per BIO-B's latest filing, from $579.8 million in the prior quarter.
• Over five years, Goodwill peaked at $579.8 million in Q4 2025 and troughed at $160.5 million in Q2 2025.
• A 5-year average of $417.7 million and a median of $411.5 million in 2023 frame the typical range for Goodwill.
• On a YoY basis, Goodwill climbed as much as 41.24% in 2025 and fell as far as 61.05% in 2025.
• A 5-year view of Goodwill shows it stood at $406.5 million in 2022, then advanced by 1.75% to $413.6 million in 2023, then dropped by 0.75% to $410.5 million in 2024, then jumped by 41.24% to $579.8 million in 2025, then slipped by 0.47% to $577.1 million in 2026.
• Business Quant data shows BIO-B's Goodwill at $577.1 million in Q1 2026, $579.8 million in Q4 2025, and $578.7 million in Q3 2025.